查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585680

生物技术服务市场：按服务类型、最终用户划分 - 全球预测 2025-2030

Biotechnology Services Market by Service Type, End-Users (Biotechnology Companies, Clinical Research Organizations, Contract Manufacturers Organizations ) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物技术服务市值为1,930.5亿美元，预计到2024年将达到2,146.9亿美元，复合年增长率为11.60%，到2030年将达到4,162.5亿美元。

生物技术服务市场涵盖旨在支持生命科学公司和改进医疗解决方案的广泛服务，包括生物加工、药物发现、DNA定序、基因组学和蛋白​​质组学。对这些服务的需求源于对个人化医疗不断增长的需求、生物製药的突破以及对创新医疗解决方案的迫切需求。这些服务应用于药物和生物技术产品开发的各个阶段，从研究和临床前测试到监管核准和上市后监督，为研究机构、医疗保健提供者和製药公司等组织提供支援。该市场的关键成长要素包括基因工程的进步、生物技术研发的大力投资以及需要创新治疗的慢性病的流行。 CRISPR技术、再生医学、生物资讯学等领域充满商机。相关人员可以透过投资联合伙伴关係、加强服务组合和关注新兴市场来利用这些优势。然而，存在阻碍市场扩张的限制，包括严格的监管环境、高昂的营运成本以及围绕基因改造的伦理问题。此外，获得熟练专家的协助和资料管理挑战也是主要障碍。具有巨大业务成长潜力的创新研发领域包括开发负担得起的定序方法、简化生物流程以及将人工智慧和机器学习整合到药物发现中进行预测分析。对于市场参与企业和现有企业而言，对市场动态的研究揭示了一个充满希望但竞争激烈的格局，其中适应性、技术力和策略联盟对于持续成长至关重要。此外，注重以患者为中心的方法和永续性实践可以提供明显的优势，符合绿色和人性化的医疗保健解决方案的全球趋势。总体而言，生物技术服务市场是一个充满活力的环境，对于那些准备好透过创新策略应对复杂情况的人来说充满了可能性。

主要市场统计
基准年[2023] 1930.5亿美元
预测年份 [2024] 2146.9亿美元
预测年份 [2030] 4162.5亿美元
复合年增长率（%） 11.60%

市场动态：揭示快速发展的生物技术服务市场的关键市场洞察

供需的动态交互作用正在改变生物技术服务市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 製药公司增加药物开发业务外包
    • 学术研究活动的活性化和高效设施的需求
    • 不断扩大合约研究和製造服务
  • 市场限制因素
    • 对外包服务的绩效、品质和保密性的担忧
  • 市场机会
    • 生物技术设备和技术的进步
    • 活性化生物技术研究的资金筹措和投资活动
  • 市场问题
    • 生物技术外包服务严格的监管合规要求

波特五力：驾驭生技服务市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解生物技术服务市场的外部影响

外部宏观环境因素在塑造生物技术服务市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解生物技术服务市场的竞争格局

生物技术服务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵生物技术服务市场供应商的绩效评估

FPNV 定位矩阵是评估生物技术服务市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：制定生物技术服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物技术服务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药公司增加药物开发业务外包
      • 学术研究活动的增加和对高效设施的需求
      • 扩大合约研究和製造服务
    • 抑制因素
      • 对外包服务的绩效、品质和保密性的担忧
    • 机会
      • 生物技术设备和技术的进步
      • 生物技术研究的新资金筹措和投资活动
    • 任务
      • 生技外包服务严格合规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生物技术服务市场：依服务类型

  • 介绍
  • 细胞处理和分离
  • 招募捐款者
  • 食品生物技术服务
  • 预防和疾病控制
  • 公共参与活动
  • 组织收集

第七章生物技术服务市场：依最终用户分类

  • 介绍
  • 生技公司
  • 临床研究组织（CRO）
  • 契约製造组织 (CMO)

第八章美洲生物技术服务市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物技术服务市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲生物技术服务市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Almac Group Limited
  • AnaBioTec NV
  • Avance Clinical Pty Ltd.
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Biogen Inc.
  • BioIVT LLC
  • Caidya
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • CMIC Group
  • Contract Pharmacal Corp.
  • Crown Bioscience, Inc.
  • Danaher Corporation
  • Eurofins Scientific Limited
  • GE HealthCare Technologies Inc.
  • GenScript BIoTech Corporation
  • ICON PLC
  • ITR Laboratories Canada
  • Kaneka Corporation
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
Product Code: MRR-521BAA36EA71

The Biotechnology Services Market was valued at USD 193.05 billion in 2023, expected to reach USD 214.69 billion in 2024, and is projected to grow at a CAGR of 11.60%, to USD 416.25 billion by 2030.

The Biotechnology Services market encompasses a wide range of services such as bioprocessing, drug discovery, DNA sequencing, genomics, and proteomics, aimed at supporting life sciences companies and advancing healthcare solutions. The necessity for these services arises from the increasing demand for personalized medicine, breakthroughs in biopharmaceuticals, and the pressing need for innovative healthcare solutions. These services are applied across various stages of pharmaceutical and biotechnological product development, from research and pre-clinical trials to regulatory approvals and post-market studies, supporting organizations like research institutions, healthcare providers, and pharmaceutical companies. Key growth influencers in this market include advancements in genetic engineering, robust investments in biotechnology R&D, and a growing prevalence of chronic diseases necessitating innovative treatments. Opportunities abound in areas such as CRISPR technology, regenerative medicine, and bioinformatics; stakeholders can harness these by investing in collaborative partnerships, enhancing service portfolios, and focusing on emerging markets. Nonetheless, limitations persist, such as stringent regulatory landscapes, high operational costs, and ethical concerns around genetic modifications, which can impede market expansion. Additionally, access to skilled professionals and data management challenges present significant hurdles. Innovative research areas with high potential for business growth include developing affordable sequencing methods, improving bioprocessing efficiencies, and integrating AI and machine learning for predictive analytics in drug discovery. For market entrants and existing players, insights into market dynamics reveal a promising but competitive landscape where adaptability, technological prowess, and strategic alliances will be essential for sustained growth. Emphasizing patient-centric approaches and sustainability practices may also offer distinct advantages in line with global trends towards eco-conscious and human-centered healthcare solutions. Overall, the biotechnology services market presents a vibrant environment ripe with potential for those ready to navigate its complexities with innovative strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 193.05 billion
Estimated Year [2024] USD 214.69 billion
Forecast Year [2030] USD 416.25 billion
CAGR (%) 11.60%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Services Market

The Biotechnology Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing outsourcing of drug development activities by pharmaceutical companies
    • Growing rate of academic research activities and need for efficient facilities
    • Rising expansion of contract research and manufacturing services
  • Market Restraints
    • Concerns over performance, quality and confidentiality of outsourcing services
  • Market Opportunities
    • Advancements in biotechnology instruments and techniques
    • Emerging funding and investment activities in biotechnology research
  • Market Challenges
    • Stringent regulatory compliances for biotechnology outsourcing services

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Services Market

A detailed market share analysis in the Biotechnology Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Services Market

A strategic analysis of the Biotechnology Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service Type, market is studied across Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services, Prevention & Disease Control, Public Engagement Activities, and Tissue Collection.
  • Based on End-Users, market is studied across Biotechnology Companies, Clinical Research Organizations(CROs), and Contract Manufacturers Organizations (CMOs).
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing outsourcing of drug development activities by pharmaceutical companies
      • 5.1.1.2. Growing rate of academic research activities and need for efficient facilities
      • 5.1.1.3. Rising expansion of contract research and manufacturing services
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over performance, quality and confidentiality of outsourcing services
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biotechnology instruments and techniques
      • 5.1.3.2. Emerging funding and investment activities in biotechnology research
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory compliances for biotechnology outsourcing services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biotechnology Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Cell Processing & Isolation
  • 6.3. Donor Recruitment
  • 6.4. Food Biotechnology Services
  • 6.5. Prevention & Disease Control
  • 6.6. Public Engagement Activities
  • 6.7. Tissue Collection

7. Biotechnology Services Market, by End-Users

  • 7.1. Introduction
  • 7.2. Biotechnology Companies
  • 7.3. Clinical Research Organizations(CROs)
  • 7.4. Contract Manufacturers Organizations (CMOs)

8. Americas Biotechnology Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biotechnology Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Almac Group Limited
  • 3. AnaBioTec NV
  • 4. Avance Clinical Pty Ltd.
  • 5. Azenta Life Sciences
  • 6. Becton, Dickinson and Company
  • 7. Biogen Inc.
  • 8. BioIVT LLC
  • 9. Caidya
  • 10. Catalent, Inc.
  • 11. Charles River Laboratories International, Inc.
  • 12. CMIC Group
  • 13. Contract Pharmacal Corp.
  • 14. Crown Bioscience, Inc.
  • 15. Danaher Corporation
  • 16. Eurofins Scientific Limited
  • 17. GE HealthCare Technologies Inc.
  • 18. GenScript Biotech Corporation
  • 19. ICON PLC
  • 20. ITR Laboratories Canada
  • 21. Kaneka Corporation
  • 22. Laboratory Corporation of America Holdings
  • 23. Merck KGaA
  • 24. Novartis AG
  • 25. Siemens Healthcare GmbH
  • 26. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. BIOTECHNOLOGY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOTECHNOLOGY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOTECHNOLOGY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOTECHNOLOGY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CELL PROCESSING & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DONOR RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY FOOD BIOTECHNOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PREVENTION & DISEASE CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PUBLIC ENGAGEMENT ACTIVITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TISSUE COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS(CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONTRACT MANUFACTURERS ORGANIZATIONS (CMOS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023